Back
CRISPR Therapeutics AG Stock Price Chart
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
53.28
Seasonality Move:
27.39%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.82 | Sell |
| 20-day SMA: | 56.05 | Sell |
| 50-day SMA: | 66.2 | Sell |
| 200-day SMA: | 59.36 | Sell |
| 8-day EMA: | 55.02 | Sell |
| 20-day EMA: | 57.12 | Sell |
| 50-day EMA: | 62.35 | Sell |
| 200-day EMA: | 61.92 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3 | Sell |
| Relative Strength Index (14 RSI): | 34.38 | Sell |
| Chaikin Money Flow: | -437080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.77 - 61.43) | Sell |
| Bollinger Bands (100): | (57.92 - 76.08) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 53.29 while CRSP 8-day simple moving average is 54.82, which is a Sell signal.
- The stock price of CRSP is 53.29 while CRISPR Therapeutics AG 20-day SMA is 56.05, which makes it a Sell.
- CRISPR Therapeutics AG 50-day simple moving average is 66.20 while CRSP share price is 53.29, making it a Sell technically.
- CRSP stock price is 53.29 and CRISPR Therapeutics AG 200-day simple moving average is 59.36, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $53.29. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.52B
Price in USD:
53.29
Share Volume:
1.52M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
37.55
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 53.29 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 53.29 while CRSP 8-day exponential moving average is 55.02, which is a Sell signal.
- The stock price of CRSP is 53.29 while CRISPR Therapeutics AG 20-day EMA is 57.12, which makes it a Sell.
- CRISPR Therapeutics AG 50-day exponential moving average is 62.35 while CRSP share price is 53.29, making it a Sell technically.
- CRSP stock price is 53.29 and CRISPR Therapeutics AG 200-day simple moving average is 61.92, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.17 per share, a decrease this year of $2.67 per share, and an increase next year of $1.62 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -3, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 34.38, which suggest CRISPR Therapeutics AG is oversold
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (53.77 - 61.43), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (57.92 - 76.08), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.